In 2019, a study conducted on 142 CML patients demonstrated that there were no differences in the mean values of BCR-ABL1 obtained by dPCR between e13a2 and e14a2 patients. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.